USD 0.27
(0.33%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 44 Thousand USD | -16.04% |
2022 | 52.4 Thousand USD | -94.68% |
2021 | 986 Thousand USD | -55.55% |
2020 | 2.21 Million USD | -20.13% |
2019 | 2.77 Million USD | 32.43% |
2018 | 2.09 Million USD | 75.33% |
2017 | 1.19 Million USD | 37.47% |
2016 | 870 Thousand USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 63 Thousand USD | 0.0% |
2024 Q1 | 63 Thousand USD | 43.18% |
2023 Q1 | 70 Thousand USD | 33.57% |
2023 Q2 | 59 Thousand USD | -15.71% |
2023 Q3 | 64 Thousand USD | 8.47% |
2023 FY | 44 Thousand USD | -16.04% |
2023 Q4 | 44 Thousand USD | -31.25% |
2022 Q2 | 43 Thousand USD | -95.94% |
2022 FY | 52.4 Thousand USD | -94.68% |
2022 Q4 | 52.4 Thousand USD | 0.0% |
2022 Q3 | - USD | -100.0% |
2022 Q1 | 1.05 Million USD | 7.4% |
2021 Q1 | 2.24 Million USD | 1.4% |
2021 Q2 | 2.32 Million USD | 3.29% |
2021 Q3 | 997 Thousand USD | -57.08% |
2021 Q4 | 986 Thousand USD | -1.1% |
2021 FY | 986 Thousand USD | -55.55% |
2020 FY | 2.21 Million USD | -20.13% |
2020 Q4 | 2.21 Million USD | -14.43% |
2020 Q1 | 2.77 Million USD | -0.14% |
2020 Q3 | 2.59 Million USD | -4.14% |
2020 Q2 | 2.7 Million USD | -2.49% |
2019 Q1 | 2.21 Million USD | 5.72% |
2019 Q3 | 2.57 Million USD | 9.73% |
2019 Q4 | 2.77 Million USD | 7.97% |
2019 FY | 2.77 Million USD | 32.43% |
2019 Q2 | 2.34 Million USD | 5.73% |
2018 Q4 | 2.09 Million USD | 63.7% |
2018 Q3 | 1.28 Million USD | 1.83% |
2018 Q2 | 1.25 Million USD | 37.64% |
2018 Q1 | 914 Thousand USD | -23.58% |
2018 FY | 2.09 Million USD | 75.33% |
2017 Q4 | 1.19 Million USD | 0.0% |
2017 FY | 1.19 Million USD | 37.47% |
2016 FY | 870 Thousand USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Perspective Therapeutics, Inc. | 1.4 Million USD | 96.877% |
Electromed, Inc. | 3.71 Million USD | 98.815% |
Senseonics Holdings, Inc. | 8.77 Million USD | 99.499% |
Xtant Medical Holdings, Inc. | 36.88 Million USD | 99.881% |